Honokiol's Effects on Pancreatic Cancer Cells
Author Information
Author(s): Sumit Arora, Arun Bhardwaj, Sanjeev K. Srivastava, Seema Singh, Steven McClellan, Bin Wang, Ajay P. Singh
Primary Institution: University of South Alabama
Hypothesis
Honokiol can inhibit the growth of pancreatic cancer cells and enhance the effects of gemcitabine.
Conclusion
Honokiol effectively inhibits pancreatic cancer cell growth and enhances the cytotoxic effects of gemcitabine.
Supporting Evidence
- Honokiol caused cell cycle arrest at the G1 phase in pancreatic cancer cells.
- Treatment with honokiol led to increased apoptosis in both MiaPaCa and Panc1 cells.
- Honokiol reduced the expression of cyclins and cyclin-dependent kinases while increasing Cdk inhibitors.
- Honokiol enhanced the cytotoxic effects of gemcitabine in pancreatic cancer cells.
Takeaway
Honokiol is a natural compound that can help fight pancreatic cancer by stopping cancer cells from growing and making chemotherapy work better.
Methodology
The study used two pancreatic cancer cell lines, MiaPaCa and Panc1, to assess the effects of honokiol on cell growth, cell cycle progression, and apoptosis induction.
Limitations
The study was conducted in vitro, and results may not fully translate to in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website